| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 12/06/2024 | 22:15 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities | NASDAQ:ECOR | electroCore Inc |
| 11/06/2024 | 14:00 | GlobeNewswire Inc. | electroCore to Join Russell Microcap® Index | NASDAQ:ECOR | electroCore Inc |
| 07/06/2024 | 22:33 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:ECOR | electroCore Inc |
| 07/06/2024 | 22:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ECOR | electroCore Inc |
| 06/06/2024 | 14:00 | GlobeNewswire Inc. | electroCore, Inc. Announces Closing of $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules | NASDAQ:ECOR | electroCore Inc |
| 04/06/2024 | 22:07 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:ECOR | electroCore Inc |
| 03/06/2024 | 16:26 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ECOR | electroCore Inc |
| 03/06/2024 | 14:30 | GlobeNewswire Inc. | electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules | NASDAQ:ECOR | electroCore Inc |
| 29/05/2024 | 15:00 | GlobeNewswire Inc. | Firefly Neuroscience, an AI-Driven Brain Health Company, Names Brian S. Posner to its Board of Directors, Upon Closing of Its Merger Transaction with WaveDancer | NASDAQ:ECOR | electroCore Inc |
| 08/05/2024 | 22:18 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ECOR | electroCore Inc |
| 08/05/2024 | 22:05 | GlobeNewswire Inc. | electroCore Announces First Quarter 2024 Financial Results | NASDAQ:ECOR | electroCore Inc |
| 03/05/2024 | 22:05 | GlobeNewswire Inc. | electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) | NASDAQ:ECOR | electroCore Inc |
| 01/05/2024 | 14:04 | GlobeNewswire Inc. | electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024 | NASDAQ:ECOR | electroCore Inc |
| 30/04/2024 | 14:00 | GlobeNewswire Inc. | Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion | NASDAQ:ECOR | electroCore Inc |
| 08/04/2024 | 14:30 | GlobeNewswire Inc. | electroCore Announces the Launch of Truvaga Plus® for General Wellness | NASDAQ:ECOR | electroCore Inc |
| 02/04/2024 | 14:00 | GlobeNewswire Inc. | electroCore Expands Intellectual Property Portfolio | NASDAQ:ECOR | electroCore Inc |
| 13/03/2024 | 21:05 | GlobeNewswire Inc. | electroCore Announces Fourth Quarter and Full Year 2023 Financial Results | NASDAQ:ECOR | electroCore Inc |
| 12/03/2024 | 13:00 | GlobeNewswire Inc. | electroCore to Participate in Upcoming Investor Conferences | NASDAQ:ECOR | electroCore Inc |
| 05/03/2024 | 22:05 | GlobeNewswire Inc. | electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024 | NASDAQ:ECOR | electroCore Inc |
| 18/12/2023 | 22:15 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:ECOR | electroCore Inc |
| 18/12/2023 | 22:10 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial ownership | NASDAQ:ECOR | electroCore Inc |
| 12/12/2023 | 14:00 | GlobeNewswire Inc. | electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology | NASDAQ:ECOR | electroCore Inc |
| 07/12/2023 | 13:53 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:ECOR | electroCore Inc |
| 15/11/2023 | 14:15 | GlobeNewswire Inc. | Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023 | NASDAQ:ECOR | electroCore Inc |
| 08/11/2023 | 22:01 | GlobeNewswire Inc. | electroCore Announces Third Quarter 2023 Financial Results | NASDAQ:ECOR | electroCore Inc |
| 07/11/2023 | 14:00 | GlobeNewswire Inc. | electroCore to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum | NASDAQ:ECOR | electroCore Inc |
| 24/10/2023 | 14:00 | GlobeNewswire Inc. | Data Highlighting Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Symptoms of Gastroparesis Presented at 2023 American College of Gastroenterology Annual Meeting | NASDAQ:ECOR | electroCore Inc |
| 17/10/2023 | 14:00 | GlobeNewswire Inc. | electroCore Announces Two-Year Extension of gammaCore™ Device Listing in the NHS Supply Chain Catalogue | NASDAQ:ECOR | electroCore Inc |
| 11/10/2023 | 14:00 | GlobeNewswire Inc. | electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology | NASDAQ:ECOR | electroCore Inc |
| 10/10/2023 | 14:00 | GlobeNewswire Inc. | Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress | NASDAQ:ECOR | electroCore Inc |